Shan Kevin - Bristol-Myers Squibb/AstraZeneca

基本信息

浏览量：13

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 40 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Impact of Prior Biologic/Janus Kinase Inhibitor Therapy on the Efficacy of Etrasimod: Subgroup Analysis from the Phase 3 ELEVATE UC 52 and ELEVATE UC 12 Trials

Severine Vermeire,Bruce E. Sands,Laurent Peyrin-Biroulet,Geert D'Haens,Julian Panes,Andres J. Yarur,Douglas C. Wolf,Timothy E. Ritter,Stefan Schreiber,Kevin Shan,Christopher J. Rabbat,Michael V. Chiorean,Filip Baert,Marla C. Dubinsky,Martina Goetsch,Silvio Danese,Brian G. Feagan

AMERICAN JOURNAL OF GASTROENTEROLOGY（2023）

引用0浏览0引用

S1145 Corticosteroid-Free Efficacy Outcomes in Patients Receiving Concomitant Corticosteroids at Baseline in the Etrasimod ELEVATE UC 52 Trial

Bruce E. Sands,Yvette Leung,David T. Rubin,Krisztina B. Gecse,Julian Panés,Martina Goetsch,Wenjin Wang,Kevin Shan,John C. Woolcott,Christina C. Smith,Karolina Wosik,Stefan Schreiber

American Journal of Gastroenterology（2023）

引用0浏览0引用

Tu1702 ACHIEVEMENT OF CORTICOSTEROID-FREE CLINICAL ENDPOINTS IN SUBJECTS WITH ULCERATIVE COLITIS: AN ANALYSIS OF THE PHASE 3 ELEVATE UC 52 TRIAL

Bruce E. Sands,David T. Rubin,Julián Panés,Krisztina Gecse,Yvette Leung,Martina Goetsch,Wenjin Wang,Kevin Shan,John Woolcott,Christina C. Smith,Karolina Wosik,Stefan Schreiber

Gastroenterology（2023）

引用0浏览0引用

948 ETRASIMOD FOR THE TREATMENT OF ULCERATIVE COLITIS: UP TO 2.5 YEARS OF POOLED SAFETY DATA FROM GLOBAL CLINICAL TRIALS

Severine Vermeire,Laurent Peyrin-Biroulet,Julian Panes,Miguel D. Regueiro,Paulo G. Kotze,Aline Charabaty,Martina Goetsch,Kevin Shan,Joseph Wu,Aoibhinn McDonnell,John Woolcott,Silvio Danese

GASTROENTEROLOGYno. 6 (2023): S207-S207

引用1浏览0引用

Corticosteroid-Free Efficacy Outcomes in Patients Receiving Concomitant Corticosteroids at Baseline in the Etrasimod ELEVATE UC 52 Trial

Bruce E. Sands,Yvette Leung,David T. Rubin,Krisztina B. Gecse,Julian Panes,Martina Goetsch,Wenjin Wang,Kevin Shan,John C. Woolcott,Christina C. Smith,Karolina Wosik,Stefan Schreiber

AMERICAN JOURNAL OF GASTROENTEROLOGYno. 10 (2023): S876-S877

引用0浏览0引用

S1067 Impact of Prior Biologic/Janus Kinase Inhibitor Therapy on the Efficacy of Etrasimod: Subgroup Analysis from the Phase 3 ELEVATE UC 52 and ELEVATE UC 12 Trials

Séverine Vermeire,Bruce E. Sands,Laurent Peyrin-Biroulet,Geert D'Haens,Julian Panés,Andres J. Yarur,Douglas C. Wolf,Timothy E. Ritter,Stefan Schreiber,Kevin Shan,Christopher J. Rabbat,Michael V. Chiorean,Filip Baert,Marla C. Dubinsky,Martina Goetsch,Silvio Danese,Brian G. Feagan

American Journal of Gastroenterologyno. 10S (2023)

引用0浏览0引用

EFFICACY OF ETRASIMOD ON SYMPTOMATIC RELIEF IN PATIENTS WITH ULCERATIVE COLITIS: AN ANALYSIS OF THE PHASE 3 ELEVATE UC 52 AND ELEVATE UC 12 TRIALS

Maria Chaparro,Alessandro Armuzzi,Peter M. Irving,Matthieu Allez,Marla C. Dubinsky,Bruce E. Sands,Martina Goetsch,Wenjin Wang,Kevin Shan,John Woolcott,Lauren Bartolome,Karolina Wosik,Remo Panaccione

GASTROENTEROLOGYno. 6 (2023): S1099-S1100

引用0浏览0引用

S1061 Efficacy and Safety of Etrasimod in Patients with and Without Concomitant Corticosteroid Treatment in the Phase 3 ELEVATE UC 52 and ELEVATE UC 12 Trials

Bruce E. Sands,Krisztina B. Gecse,David T. Rubin,Yvette Leung,Julian Panes,Martina Goetsch,Wenjin Wang,Kevin Shan,John C. Woolcott,Christina C. Smith,Karolina Wosik,Stefan Schreiber

AMERICAN JOURNAL OF GASTROENTEROLOGYno. 10 (2023): S808-S809

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn